Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life - Wikidata - awgldk - TriplyDB

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life

http://www.wikidata.org/entity/Q34786346

about

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis.A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.Fibrinolysis and the control of blood coagulation.Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?The intrinsic pathway of coagulation: a target for treating thromboembolic disease?Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging.The central role of thrombin in hemostasis.Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI Plasma and cellular contributions to fibrin network formation, structure and stability.Insights into thrombin activatable fibrinolysis inhibitor function and regulation.In vivo regulation of plasminogen function by plasma carboxypeptidase B.Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice.Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots.Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis.

P2860

Q24623508-45A0F234-34A3-495C-8684-723A4A1E8D09 Q28512072-656202A8-78A6-4E1F-BD17-3109F716306C Q28571160-E827E635-1A95-460E-9586-90F380D53059 Q33439281-90A92048-9E90-4BAF-8ED3-2AE5E6F40C56 Q33640335-30F11AA2-5645-43E4-9BF9-278518456CD3 Q33815771-8718B79E-1596-443E-9EFC-9A695365A09D Q34245642-74D168B1-F55D-40FA-B616-8D6CC3DCD010 Q34869404-062B09A3-08EC-4B58-88E7-11B84699DD6A Q35008316-7FFFBDE4-2E97-4148-BDE1-D9C5D5EC2C03 Q35039847-3DB112E6-62BA-4952-B2DB-0FC043E7DC4D Q35088199-63BF4227-3C96-49DF-810D-1B9BBF524D79 Q35159922-6EC8B1E6-CD85-46B0-BBC0-BC191603B9FE Q35208114-F2AE2141-A906-4759-8715-C4CA2B9E6F29 Q35642856-B7DE6031-6F9B-4DE5-9485-EEF884B46BBD Q35849691-A3412A89-4A16-42F4-B6AD-680242FB0B67 Q35882816-06B566D8-75FB-47ED-BF89-4A18E68B590F Q35903082-A5C90154-8B4A-43E1-8EF5-12F5C943C90A Q36606627-CBEFA344-E98B-48A1-9C90-9D74F974AFE7 Q36771762-4074F41E-5E04-4F93-BF3B-E027B2ABA8BE Q36860088-44D8CEB4-DED7-4C33-9E62-67AA2428DE98 Q36884335-9FA0A366-DB54-415C-9233-E4E77AAAC421 Q37071138-74C254D6-0308-4C4F-96DA-91D3C23A8405 Q37768478-6F4251A9-40DF-461F-82BA-3FF6B0FB8D3C Q38117742-8A8A3EDB-43FC-4304-8807-8501D57B4386 Q39739972-BAC95A67-C23E-4086-B357-4C9D4BFEC336 Q41349130-ADAE6D83-1543-47D8-893D-E761E479808E Q42595647-DEE0507A-874D-45E6-8EFD-844FF104E12C Q42932498-78EEFEE5-D08F-4B79-BF2D-3A2DA3267600 Q43188588-D76F71EA-EB53-446F-8CFE-F3F7BC131204 Q45168592-CB248DF6-09E0-4B55-9F7C-9AAB1AC5451A Q46910897-2C3F9952-D1BA-48DC-B011-ED050A788EC2

P2860

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life

http://www.wikidata.org/entity/Q34786346

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Thrombin-activatable fibrinoly ...... is compatible with murine life

@ast

Thrombin-activatable fibrinoly ...... is compatible with murine life

@en

type

label

Thrombin-activatable fibrinoly ...... is compatible with murine life

@ast

Thrombin-activatable fibrinoly ...... is compatible with murine life

@en

prefLabel

Thrombin-activatable fibrinoly ...... is compatible with murine life

@ast

Thrombin-activatable fibrinoly ...... is compatible with murine life

@en

P1433

Q34786346-B3F1E419-CC1D-4C75-9743-016D63CE714A

P1476

Q34786346-78A2BE10-8E34-47CD-8618-4B937402471D

P2093

Q34786346-23D707E1-6254-41DE-B1C4-72B36F14FFA1

Q34786346-62F39127-BABA-40FE-92DC-C6919E6DFF19

Q34786346-7A57706D-8A4C-4420-8F1E-90CB73A6194B

Q34786346-7BEDE698-907F-4252-BA32-45F3449AE01A

Q34786346-AF45E79C-ABED-4FB1-894E-A2A0B1DD6F8F

Q34786346-B160B196-7D38-4B9E-A45B-0CE8E5525E71

Q34786346-C10180A0-F253-4C0E-8094-F7F04C3A5FF0

Q34786346-D529F020-EE61-4DFD-8C02-00D6F8AA50F9

Q34786346-E96C59A9-63BB-4245-906B-1603E33B2B2F

Q34786346-F9F031F4-3F2F-45DE-97B6-811AFA0A2061

P2860

Q34786346-004461CB-15F2-487B-A290-3B043026C0FE

Q34786346-0A49B674-C356-4BD7-A183-CE85E17BC453

Q34786346-11B3180A-E432-4859-AA3F-39D234A67C4A

Q34786346-1C03759B-E90E-459A-AD76-9F1F7A6ABEEB

Q34786346-307609DA-7456-4F96-A600-0381865A0182

Q34786346-3CC31788-0098-4BFE-8391-CACD4E39B287

Q34786346-4C4C0C49-AE61-49F5-AB61-67AA6ACB20D1

Q34786346-4D1BA9C1-41E0-4723-B005-964EA28A557A

Q34786346-60BC3C88-BC93-4502-A6E6-8B44F1A9D14D

Q34786346-67CB4F76-553A-48BD-9BB5-446C0B7A0D0A

P304

Q34786346-2D74767F-F177-4866-BD03-0B71FE359206

P31

Q34786346-B66098AC-C6F4-442B-A868-7F825E78ECBA

P356

Q34786346-7B9275CE-153B-4A79-A398-66DBE575A1D5

P407

Q34786346-052CD460-94AE-4DC0-BCB9-877410DBD5F1

P433

Q34786346-14C333A8-9703-4730-8255-7485E055A877

P478

Q34786346-5493B6D3-59B7-47B9-8AF6-E750E705485C

P577

Q34786346-88EE8878-E949-4E7F-9EE0-DACDB76C169D

P698

Q34786346-BCF9FE1B-6A41-41FF-AE5B-E0E65FB84818

P932

Q34786346-2AE1C303-5599-42CC-A8AF-32F77E35F85C

P356

P1433

Journal of Clinical Investigation

P1476

Thrombin-activatable fibrinoly ...... is compatible with murine life

@en

P2093

George J Broze

http://www.w3.org/2001/XMLSchema#string

John Morser

http://www.w3.org/2001/XMLSchema#string

Kathy White

http://www.w3.org/2001/XMLSchema#string

Lei Zhao

http://www.w3.org/2001/XMLSchema#string

Mariko Nagashima

http://www.w3.org/2001/XMLSchema#string

Meredith Halks-Miller

http://www.w3.org/2001/XMLSchema#string

Nina Lasky

http://www.w3.org/2001/XMLSchema#string

William P Fay

http://www.w3.org/2001/XMLSchema#string

Yanhong Zhu

http://www.w3.org/2001/XMLSchema#string

Zheng-Feng Yin

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma carboxypeptidases as regulators of the plasminogen system

Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma

Pro-carboxypeptidase R cleaves bradykinin following activation

Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma

Activation and characterization of procarboxypeptidase B from human plasma

Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not

Characterization of mouse thrombin-activatable fibrinolysis inhibitor

Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin

P304

101-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0212119

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11781355

http://www.w3.org/2001/XMLSchema#string

P932

150816

http://www.w3.org/2001/XMLSchema#string